{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:53:51Z","timestamp":1790009631476,"version":"4.0.1"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T00:00:00Z","timestamp":1433462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s12975-015-0409-7","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T10:17:32Z","timestamp":1433413052000},"page":"264-275","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke"],"prefix":"10.1007","volume":"6","author":[{"given":"Vasileios-Arsenios","family":"Lioutas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Alfaro-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Bedoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Chih","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela A.","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,5]]},"reference":[{"issue":"7","key":"409_CR1","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"WN Kernan","year":"2014","unstructured":"Kernan WN et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2014;45(7):2160\u2013236.","journal-title":"Stroke"},{"issue":"9859","key":"409_CR2","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095\u2013128.","journal-title":"Lancet"},{"issue":"9859","key":"409_CR3","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","volume":"380","author":"CJ Murray","year":"2012","unstructured":"Murray CJ et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197\u2013223.","journal-title":"Lancet"},{"issue":"3","key":"409_CR4","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","volume":"44","author":"EC Jauch","year":"2013","unstructured":"Jauch EC et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2013;44(3):870\u2013947.","journal-title":"Stroke"},{"issue":"25","key":"409_CR5","first-page":"2433","volume":"368","author":"A Ciccone","year":"2013","unstructured":"Ciccone A, Valvassori L. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013;368(25):2433\u20134.","journal-title":"N Engl J Med"},{"issue":"10","key":"409_CR6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1214300","volume":"368","author":"JP Broderick","year":"2013","unstructured":"Broderick JP et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368(10):893\u2013903.","journal-title":"N Engl J Med"},{"issue":"10","key":"409_CR7","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1212793","volume":"368","author":"CS Kidwell","year":"2013","unstructured":"Kidwell CS et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368(10):914\u201323.","journal-title":"N Engl J Med"},{"issue":"11","key":"409_CR8","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1414905","volume":"372","author":"M Goyal","year":"2015","unstructured":"Goyal M et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019\u201330.","journal-title":"N Engl J Med"},{"issue":"11","key":"409_CR9","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","volume":"372","author":"BC Campbell","year":"2015","unstructured":"Campbell BC et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372(11):1009\u201318.","journal-title":"N Engl J Med"},{"issue":"1","key":"409_CR10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411587","volume":"372","author":"OA Berkhemer","year":"2015","unstructured":"Berkhemer OA et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11\u201320.","journal-title":"N Engl J Med"},{"issue":"3","key":"409_CR11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1474-4422(09)70041-9","volume":"8","author":"GA Donnan","year":"2009","unstructured":"Donnan GA et al. Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol. 2009;8(3):261\u20139.","journal-title":"Lancet Neurol"},{"issue":"2","key":"409_CR12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jocn.2008.04.002","volume":"16","author":"M Ebinger","year":"2009","unstructured":"Ebinger M et al. Imaging the penumbra\u2014strategies to detect tissue at risk after ischemic stroke. J Clin Neurosci. 2009;16(2):178\u201387.","journal-title":"J Clin Neurosci"},{"issue":"8","key":"409_CR13","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1179\/016164104X2357","volume":"26","author":"Z Zheng","year":"2004","unstructured":"Zheng Z, Yenari MA. Post-ischemic inflammation: molecular mechanisms and therapeutic implications. Neurol Res. 2004;26(8):884\u201392.","journal-title":"Neurol Res"},{"issue":"12","key":"409_CR14","first-page":"1844","volume":"61","author":"NS Ward","year":"2004","unstructured":"Ward NS, Cohen LG. Mechanisms underlying recovery of motor function after stroke. Arch Neurol. 2004;61(12):1844\u20138.","journal-title":"Arch Neurol"},{"issue":"5","key":"409_CR15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cnr.2006.09.008","volume":"6","author":"ZS Vexler","year":"2006","unstructured":"Vexler ZS, Tang XN, Yenari MA. Inflammation in adult and neonatal stroke. Clin Neurosci Res. 2006;6(5):293\u2013313.","journal-title":"Clin Neurosci Res"},{"issue":"1\u20132","key":"409_CR16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2006.11.014","volume":"184","author":"Q Wang","year":"2007","unstructured":"Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol. 2007;184(1\u20132):53\u201368.","journal-title":"J Neuroimmunol"},{"issue":"7\u20138","key":"409_CR17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuint.2007.04.026","volume":"50","author":"AS Hazell","year":"2007","unstructured":"Hazell AS. Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies. Neurochem Int. 2007;50(7\u20138):941\u201353.","journal-title":"Neurochem Int"},{"issue":"2","key":"409_CR18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/01.STR.0000054047.14853.AD","volume":"34","author":"MA Moskowitz","year":"2003","unstructured":"Moskowitz MA, Lo EH. Neurogenesis and apoptotic cell death. Stroke. 2003;34(2):324\u20136.","journal-title":"Stroke"},{"issue":"Pt 1","key":"409_CR19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/brain\/awh645","volume":"129","author":"T Sairanen","year":"2006","unstructured":"Sairanen T et al. Apoptosis dominant in the periinfarct area of human ischaemic stroke\u2013a possible target of antiapoptotic treatments. Brain. 2006;129(Pt 1):189\u201399.","journal-title":"Brain"},{"issue":"5","key":"409_CR20","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1161\/STROKEAHA.108.531632","volume":"40","author":"BR Broughton","year":"2009","unstructured":"Broughton BR, Reutens DC, Sobey CG. Apoptotic mechanisms after cerebral ischemia. Stroke. 2009;40(5):e331\u20139.","journal-title":"Stroke"},{"issue":"4","key":"409_CR21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10495-008-0304-8","volume":"14","author":"J Yuan","year":"2009","unstructured":"Yuan J. Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke. Apoptosis. 2009;14(4):469\u201377.","journal-title":"Apoptosis"},{"issue":"2","key":"409_CR22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/01.STR.26.2.254","volume":"26","author":"GW Albers","year":"1995","unstructured":"Albers GW et al. Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group. Stroke. 1995;26(2):254\u20138.","journal-title":"Stroke"},{"issue":"9044","key":"409_CR23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0140-6736(05)62166-6","volume":"349","author":"SM Davis","year":"1997","unstructured":"Davis SM et al. Termination of acute stroke studies involving selfotel treatment. ASSIST Steering Committed. Lancet. 1997;349(9044):32.","journal-title":"Lancet"},{"issue":"5 Suppl 4","key":"409_CR24","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1212\/WNL.49.5_Suppl_4.S66","volume":"49","author":"KR Lees","year":"1997","unstructured":"Lees KR. Cerestat and other NMDA antagonists in ischemic stroke. Neurology. 1997;49(5 Suppl 4):S66\u20139.","journal-title":"Neurology"},{"issue":"9407","key":"409_CR25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(04)15490-1","volume":"363","author":"KW Muir","year":"2004","unstructured":"Muir KW et al. Magnesium for acute stroke (intravenous magnesium efficacy in stroke trial): randomised controlled trial. Lancet. 2004;363(9407):439\u201345.","journal-title":"Lancet"},{"issue":"13","key":"409_CR26","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1001\/jama.285.13.1719","volume":"285","author":"RL Sacco","year":"2001","unstructured":"Sacco RL et al. Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA. 2001;285(13):1719\u201328.","journal-title":"JAMA"},{"issue":"2","key":"409_CR27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.STR.32.2.461","volume":"32","author":"J Horn","year":"2001","unstructured":"Horn J et al. Very Early Nimodipine Use in Stroke (VENUS): a randomized, double-blind, placebo-controlled trial. Stroke. 2001;32(2):461\u20135.","journal-title":"Stroke"},{"key":"409_CR28","first-page":"CD002087","volume":"4","author":"PM Bath","year":"2001","unstructured":"Bath PM et al. Tirilazad for acute ischaemic stroke. Cochrane Database Syst Rev. 2001;4:CD002087.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"409_CR29","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMoa070240","volume":"357","author":"A Shuaib","year":"2007","unstructured":"Shuaib A et al. NXY-059 for the treatment of acute ischemic stroke. N Engl J Med. 2007;357(6):562\u201371.","journal-title":"N Engl J Med"},{"issue":"6","key":"409_CR30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa052980","volume":"354","author":"KR Lees","year":"2006","unstructured":"Lees KR et al. NXY-059 for acute ischemic stroke. N Engl J Med. 2006;354(6):588\u2013600.","journal-title":"N Engl J Med"},{"issue":"12","key":"409_CR31","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1161\/01.STR.0000249410.91473.44","volume":"37","author":"KR Lees","year":"2006","unstructured":"Lees KR et al. Additional outcomes and subgroup analyses of NXY-059 for acute ischemic stroke in the SAINT I trial. Stroke. 2006;37(12):2970\u20138.","journal-title":"Stroke"},{"issue":"12","key":"409_CR32","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/01.STR.0000038691.03334.71","volume":"33","author":"A Davalos","year":"2002","unstructured":"Davalos A et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke. 2002;33(12):2850\u20137.","journal-title":"Stroke"},{"issue":"9839","key":"409_CR33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(12)60813-7","volume":"380","author":"A Davalos","year":"2012","unstructured":"Davalos A et al. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet. 2012;380(9839):349\u201357.","journal-title":"Lancet"},{"key":"409_CR34","doi-asserted-by":"crossref","unstructured":"Use of anti-ICAM-1 therapy in ischemic stroke: results of the enlimomab acute stroke trial. Neurology. 2001;57(8):1428\u201334.","DOI":"10.1212\/WNL.57.8.1428"},{"issue":"33","key":"409_CR35","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.2174\/138161208786848748","volume":"14","author":"E Taoufik","year":"2008","unstructured":"Taoufik E, Probert L. Ischemic neuronal damage. Curr Pharm Des. 2008;14(33):3565\u201373.","journal-title":"Curr Pharm Des"},{"issue":"6","key":"409_CR36","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00018-003-3319-x","volume":"61","author":"M Arundine","year":"2004","unstructured":"Arundine M, Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci. 2004;61(6):657\u201368.","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"409_CR37","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1038\/jcbfm.2009.113","volume":"29","author":"KZ Chapman","year":"2009","unstructured":"Chapman KZ et al. A rapid and transient peripheral inflammatory response precedes brain inflammation after experimental stroke. J Cereb Blood Flow Metab. 2009;29(11):1764\u20138.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"409_CR38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jnen\/62.2.127","volume":"62","author":"GH Danton","year":"2003","unstructured":"Danton GH, Dietrich WD. Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol. 2003;62(2):127\u201336.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"409_CR39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.STR.0000057976.53301.69","volume":"34","author":"N Vila","year":"2003","unstructured":"Vila N et al. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke. 2003;34(3):671\u20135.","journal-title":"Stroke"},{"issue":"1","key":"409_CR40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s004419900154","volume":"301","author":"MP Mattson","year":"2000","unstructured":"Mattson MP, Culmsee C, Yu ZF. Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res. 2000;301(1):173\u201387.","journal-title":"Cell Tissue Res"},{"issue":"8","key":"409_CR41","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0149-7634(00)00040-3","volume":"24","author":"RJ Schulingkamp","year":"2000","unstructured":"Schulingkamp RJ et al. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev. 2000;24(8):855\u201372.","journal-title":"Neurosci Biobehav Rev"},{"issue":"5108","key":"409_CR42","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/2151375a0","volume":"215","author":"RU Margolis","year":"1967","unstructured":"Margolis RU, Altszuler N. Insulin in the cerebrospinal fluid. Nature. 1967;215(5108):1375\u20136.","journal-title":"Nature"},{"issue":"4694","key":"409_CR43","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1126\/science.3883490","volume":"227","author":"GL King","year":"1985","unstructured":"King GL, Johnson SM. Receptor-mediated transport of insulin across endothelial cells. Science. 1985;227(4694):1583\u20136.","journal-title":"Science"},{"issue":"1\u20133","key":"409_CR44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejphar.2004.02.040","volume":"490","author":"WA Banks","year":"2004","unstructured":"Banks WA. The source of cerebral insulin. Eur J Pharmacol. 2004;490(1\u20133):5\u201312.","journal-title":"Eur J Pharmacol"},{"key":"409_CR45","doi-asserted-by":"crossref","first-page":"384017","DOI":"10.1155\/2012\/384017","volume":"2012","author":"AI Duarte","year":"2012","unstructured":"Duarte AI, Moreira PI, Oliveira CR. Insulin in central nervous system: more than just a peripheral hormone. J Aging Res. 2012;2012:384017.","journal-title":"J Aging Res"},{"issue":"1\u20132","key":"409_CR46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF02935589","volume":"3","author":"M Adamo","year":"1989","unstructured":"Adamo M, Raizada MK, LeRoith D. Insulin and insulin-like growth factor receptors in the nervous system. Mol Neurobiol. 1989;3(1\u20132):71\u2013100.","journal-title":"Mol Neurobiol"},{"issue":"12","key":"409_CR47","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/(SICI)1096-9136(199712)14:12<1044::AID-DIA508>3.0.CO;2-F","volume":"14","author":"DF Hopkins","year":"1997","unstructured":"Hopkins DF, Williams G. Insulin receptors are widely distributed in human brain and bind human and porcine insulin with equal affinity. Diabet Med. 1997;14(12):1044\u201350.","journal-title":"Diabet Med"},{"issue":"4","key":"409_CR48","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF00965500","volume":"7","author":"J Albrecht","year":"1982","unstructured":"Albrecht J, Wroblewska B, Mossakowski MJ. The binding of insulin to cerebral capillaries and astrocytes of the rat. Neurochem Res. 1982;7(4):489\u201394.","journal-title":"Neurochem Res"},{"issue":"1","key":"409_CR49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/(SICI)1096-9861(19991206)415:1<105::AID-CNE8>3.0.CO;2-H","volume":"415","author":"D Horsch","year":"1999","unstructured":"Horsch D, Kahn CR. Region-specific mRNA expression of phosphatidylinositol 3-kinase regulatory isoforms in the central nervous system of C57BL\/6J mice. J Comp Neurol. 1999;415(1):105\u201320.","journal-title":"J Comp Neurol"},{"issue":"5","key":"409_CR50","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1523\/JNEUROSCI.06-05-01211.1986","volume":"6","author":"E Recio-Pinto","year":"1986","unstructured":"Recio-Pinto E, Rechler MM, Ishii DN. Effects of insulin, insulin-like growth factor-II, and nerve growth factor on neurite formation and survival in cultured sympathetic and sensory neurons. J Neurosci. 1986;6(5):1211\u20139.","journal-title":"J Neurosci"},{"issue":"3","key":"409_CR51","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","volume":"27","author":"MA Reger","year":"2006","unstructured":"Reger MA et al. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging. 2006;27(3):451\u20138.","journal-title":"Neurobiol Aging"},{"issue":"7","key":"409_CR52","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1172\/JCI29063","volume":"116","author":"L Plum","year":"2006","unstructured":"Plum L, Belgardt BF, Bruning JC. Central insulin action in energy and glucose homeostasis. J Clin Invest. 2006;116(7):1761\u20136.","journal-title":"J Clin Invest"},{"issue":"12","key":"409_CR53","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.2337\/diabetes.51.12.3384","volume":"51","author":"EM Bingham","year":"2002","unstructured":"Bingham EM et al. The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. Diabetes. 2002;51(12):3384\u201390.","journal-title":"Diabetes"},{"issue":"1","key":"409_CR54","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1152\/ajpregu.90725.2008","volume":"296","author":"DP Figlewicz","year":"2009","unstructured":"Figlewicz DP, Benoit SC. Insulin, leptin, and food reward: update 2008. Am J Physiol Regul Integr Comp Physiol. 2009;296(1):R9\u201319.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"8","key":"409_CR55","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1046\/j.0953-816x.2001.01740.x","volume":"14","author":"D Plitzko","year":"2001","unstructured":"Plitzko D, Rumpel S, Gottmann K. Insulin promotes functional induction of silent synapses in differentiating rat neocortical neurons. Eur J Neurosci. 2001;14(8):1412\u20135.","journal-title":"Eur J Neurosci"},{"issue":"2","key":"409_CR56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tem.2005.01.008","volume":"16","author":"L Plum","year":"2005","unstructured":"Plum L, Schubert M, Bruning JC. The role of insulin receptor signaling in the brain. Trends Endocrinol Metab. 2005;16(2):59\u201365.","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"409_CR57","first-page":"3257","volume":"86","author":"P Dandona","year":"2001","unstructured":"Dandona P et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab. 2001;86(7):3257\u201365.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"409_CR58","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1210\/jcem.87.3.8462","volume":"87","author":"A Aljada","year":"2002","unstructured":"Aljada A et al. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Metab. 2002;87(3):1419\u201322.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"409_CR59","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.2337\/diacare.26.12.3310","volume":"26","author":"P Dandona","year":"2003","unstructured":"Dandona P et al. Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9. Diabetes Care. 2003;26(12):3310\u20134.","journal-title":"Diabetes Care"},{"issue":"1","key":"409_CR60","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/01.STR.0000195175.29487.30","volume":"37","author":"R Garg","year":"2006","unstructured":"Garg R et al. Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke. 2006;37(1):267\u201373.","journal-title":"Stroke"},{"issue":"7","key":"409_CR61","first-page":"2572","volume":"85","author":"A Aljada","year":"2000","unstructured":"Aljada A et al. Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Clin Endocrinol Metab. 2000;85(7):2572\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"409_CR62","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jvs.2013.03.023","volume":"59","author":"SS Huang","year":"2014","unstructured":"Huang SS et al. The essential role of endothelial nitric oxide synthase activation in insulin-mediated neuroprotection against ischemic stroke in diabetes. J Vasc Surg. 2014;59(2):483\u201391.","journal-title":"J Vasc Surg"},{"issue":"3","key":"409_CR63","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.139.3.809","volume":"139","author":"KL Philpott","year":"1997","unstructured":"Philpott KL et al. Activated phosphatidylinositol 3-kinase and Akt kinase promote survival of superior cervical neurons. J Cell Biol. 1997;139(3):809\u201315.","journal-title":"J Cell Biol"},{"issue":"6736","key":"409_CR64","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/21224","volume":"399","author":"S Dimmeler","year":"1999","unstructured":"Dimmeler S et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;399(6736):601\u20135.","journal-title":"Nature"},{"issue":"2","key":"409_CR65","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1161\/01.HYP.28.2.202","volume":"28","author":"MK McKay","year":"1996","unstructured":"McKay MK, Hester RL. Role of nitric oxide, adenosine, and ATP-sensitive potassium channels in insulin-induced vasodilation. Hypertension. 1996;28(2):202\u20138.","journal-title":"Hypertension"},{"issue":"6","key":"409_CR66","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.bbamcr.2008.02.016","volume":"1783","author":"AI Duarte","year":"2008","unstructured":"Duarte AI et al. Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3beta signaling pathways and changes in protein expression. Biochim Biophys Acta. 2008;1783(6):994\u20131002.","journal-title":"Biochim Biophys Acta"},{"issue":"4\u20136","key":"409_CR67","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00210-007-0254-7","volume":"377","author":"H Ueda","year":"2008","unstructured":"Ueda H. Prothymosin alpha plays a key role in cell death mode-switch, a new concept for neuroprotective mechanisms in stroke. Naunyn Schmiedebergs Arch Pharmacol. 2008;377(4\u20136):315\u201323.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"5618","key":"409_CR68","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1126\/science.1081203","volume":"300","author":"J Song","year":"2003","unstructured":"Song J et al. Axons guided by insulin receptor in Drosophila visual system. Science. 2003;300(5618):502\u20135.","journal-title":"Science"},{"issue":"1\u20132","key":"409_CR69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0006-8993(00)02426-4","volume":"872","author":"LL Guyot","year":"2000","unstructured":"Guyot LL et al. The effect of topical insulin on the release of excitotoxic and other amino acids from the rat cerebral cortex during streptozotocin-induced hyperglycemic ischemia. Brain Res. 2000;872(1\u20132):29\u201336.","journal-title":"Brain Res"},{"issue":"3","key":"409_CR70","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2337\/dc13-1672","volume":"37","author":"V Novak","year":"2014","unstructured":"Novak V et al. Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes. Diabetes Care. 2014;37(3):751\u20139.","journal-title":"Diabetes Care"},{"issue":"1","key":"409_CR71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","volume":"69","author":"S Craft","year":"2012","unstructured":"Craft S et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2012;69(1):29\u201338.","journal-title":"Arch Neurol"},{"key":"409_CR72","doi-asserted-by":"crossref","unstructured":"Zhang H, et al. Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes. Diabetes. 2014.","DOI":"10.2337\/db14-1000"},{"issue":"7","key":"409_CR73","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","volume":"64","author":"JJ Lochhead","year":"2012","unstructured":"Lochhead JJ, Thorne RG. Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev. 2012;64(7):614\u201328.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1\u20132","key":"409_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.03.025","volume":"337","author":"HR Costantino","year":"2007","unstructured":"Costantino HR et al. Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm. 2007;337(1\u20132):1\u201324.","journal-title":"Int J Pharm"},{"issue":"4","key":"409_CR75","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/jps.21939","volume":"99","author":"MM Migliore","year":"2010","unstructured":"Migliore MM et al. Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations. J Pharm Sci. 2010;99(4):1745\u201361.","journal-title":"J Pharm Sci"},{"issue":"1\u20132","key":"409_CR76","first-page":"91","volume":"187","author":"XF Liu","year":"2001","unstructured":"Liu XF et al. Intranasal administration of insulin-like growth factor-I bypasses the blood\u2013brain barrier and protects against focal cerebral ischemic damage. J Neurol Sci. 2001;187(1\u20132):91\u20137.","journal-title":"J Neurol Sci"},{"issue":"Suppl 3","key":"409_CR77","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2202-9-S3-S5","volume":"9","author":"LR Hanson","year":"2008","unstructured":"Hanson LR, Frey 2nd WH. Intranasal delivery bypasses the blood\u2013brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci. 2008;9 Suppl 3:S5.","journal-title":"BMC Neurosci"},{"issue":"3","key":"409_CR78","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00126839-200708030-00001","volume":"8","author":"FW Merkus","year":"2007","unstructured":"Merkus FW, van den Berg MP. Can nasal drug delivery bypass the blood\u2013brain barrier?: questioning the direct transport theory. Drugs R&D. 2007;8(3):133\u201344.","journal-title":"Drugs R&D"},{"issue":"10","key":"409_CR79","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1212\/01.WNL.0000067993.60735.77","volume":"60","author":"P Merkus","year":"2003","unstructured":"Merkus P et al. Direct access of drugs to the human brain after intranasal drug administration? Neurology. 2003;60(10):1669\u201371.","journal-title":"Neurology"},{"issue":"2","key":"409_CR80","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","volume":"127","author":"RG Thorne","year":"2004","unstructured":"Thorne RG et al. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience. 2004;127(2):481\u201396.","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"409_CR81","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2004.02.011","volume":"151","author":"TM Ross","year":"2004","unstructured":"Ross TM et al. Intranasal administration of interferon beta bypasses the blood\u2013brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis. J Neuroimmunol. 2004;151(1\u20132):66\u201377.","journal-title":"J Neuroimmunol"},{"issue":"6","key":"409_CR82","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/BF00401839","volume":"38","author":"J Hilsted","year":"1995","unstructured":"Hilsted J et al. Intranasal insulin therapy: the clinical realities. Diabetologia. 1995;38(6):680\u20134.","journal-title":"Diabetologia"},{"issue":"10","key":"409_CR83","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","volume":"29","author":"C Benedict","year":"2004","unstructured":"Benedict C et al. Intranasal insulin improves memory in humans. Psychoneuroendocrinology. 2004;29(10):1326\u201334.","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"409_CR84","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","volume":"70","author":"MA Reger","year":"2008","unstructured":"Reger MA et al. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology. 2008;70(6):440\u20138.","journal-title":"Neurology"},{"issue":"4","key":"409_CR85","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-9384(99)00220-6","volume":"68","author":"CR Park","year":"2000","unstructured":"Park CR et al. Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Behav. 2000;68(4):509\u201314.","journal-title":"Physiol Behav"},{"issue":"1","key":"409_CR86","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.npp.1301193","volume":"32","author":"C Benedict","year":"2007","unstructured":"Benedict C et al. Intranasal insulin improves memory in humans: superiority of insulin aspart. Neuropsychopharmacology. 2007;32(1):239\u201343.","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"409_CR87","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-2008-13309","volume":"13","author":"MA Reger","year":"2008","unstructured":"Reger MA et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J Alzheimers Dis. 2008;13(3):323\u201331.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"409_CR88","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40263-013-0076-8","volume":"27","author":"J Freiherr","year":"2013","unstructured":"Freiherr J et al. Intranasal insulin as a treatment for Alzheimer\u2019s disease: a review of basic research and clinical evidence. CNS Drugs. 2013;27(7):505\u201314.","journal-title":"CNS Drugs"},{"issue":"1","key":"409_CR89","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","volume":"136","author":"WA Banks","year":"2012","unstructured":"Banks WA, Owen JB, Erickson MA. Insulin in the brain: there and back again. Pharmacol Ther. 2012;136(1):82\u201393.","journal-title":"Pharmacol Ther"},{"issue":"1\u20133","key":"409_CR90","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejphar.2013.08.008","volume":"719","author":"B Cholerton","year":"2013","unstructured":"Cholerton B, Baker LD, Craft S. Insulin, cognition, and dementia. Eur J Pharmacol. 2013;719(1\u20133):170\u20139.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"409_CR91","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3233\/JAD-2012-120202","volume":"31","author":"B Cholerton","year":"2012","unstructured":"Cholerton B et al. Insulin and sex interactions in older adults with mild cognitive impairment. J Alzheimers Dis. 2012;31(2):401\u201310.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"409_CR92","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12035-011-8229-6","volume":"46","author":"HB Schioth","year":"2012","unstructured":"Schioth HB et al. Brain insulin signaling and Alzheimer\u2019s disease: current evidence and future directions. Mol Neurobiol. 2012;46(1):4\u201310.","journal-title":"Mol Neurobiol"},{"issue":"10","key":"409_CR93","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.metabol.2005.04.026","volume":"54","author":"C Benedict","year":"2005","unstructured":"Benedict C et al. Immediate but not long-term intranasal administration of insulin raises blood pressure in human beings. Metabolism. 2005;54(10):1356\u201361.","journal-title":"Metabolism"},{"issue":"2","key":"409_CR94","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/scnp.2003.50012","volume":"8","author":"DP Figlewicz","year":"2003","unstructured":"Figlewicz DP. Insulin, food intake, and reward. Semin Clin Neuropsychiatry. 2003;8(2):82\u201393.","journal-title":"Semin Clin Neuropsychiatry"},{"issue":"7","key":"409_CR95","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","volume":"100","author":"W Farris","year":"2003","unstructured":"Farris W et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A. 2003;100(7):4162\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"409_CR96","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.exger.2010.11.032","volume":"46","author":"C Humpel","year":"2011","unstructured":"Humpel C. Chronic mild cerebrovascular dysfunction as a cause for Alzheimer\u2019s disease? Exp Gerontol. 2011;46(4):225\u201332.","journal-title":"Exp Gerontol"},{"issue":"11","key":"409_CR97","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.exger.2012.07.014","volume":"47","author":"LG Exalto","year":"2012","unstructured":"Exalto LG et al. An update on type 2 diabetes, vascular dementia and Alzheimer\u2019s disease. Exp Gerontol. 2012;47(11):858\u201364.","journal-title":"Exp Gerontol"},{"issue":"10","key":"409_CR98","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1532-5415.2007.01378.x","volume":"55","author":"DS Dede","year":"2007","unstructured":"Dede DS et al. Assessment of endothelial function in Alzheimer\u2019s disease: is Alzheimer\u2019s disease a vascular disease? J Am Geriatr Soc. 2007;55(10):1613\u20137.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"409_CR99","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3233\/JAD-2012-121294","volume":"33","author":"Y Yang","year":"2013","unstructured":"Yang Y et al. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes. J Alzheimers Dis. 2013;33(2):329\u201338.","journal-title":"J Alzheimers Dis"},{"key":"409_CR100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1750-1326-5-46","volume":"5","author":"X Wang","year":"2010","unstructured":"Wang X et al. Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model. Mol Neurodegener. 2010;5:46.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"409_CR101","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/path.2912","volume":"225","author":"Y Liu","year":"2011","unstructured":"Liu Y et al. Deficient brain insulin signalling pathway in Alzheimer\u2019s disease and diabetes. J Pathol. 2011;225(1):54\u201362.","journal-title":"J Pathol"},{"issue":"7\u20138","key":"409_CR102","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s007020200082","volume":"109","author":"S Hoyer","year":"2002","unstructured":"Hoyer S. The aging brain. Changes in the neuronal insulin\/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review. J Neural Transm. 2002;109(7\u20138):991\u20131002.","journal-title":"J Neural Transm"},{"issue":"9","key":"409_CR103","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.2337\/db12-0025","volume":"61","author":"K Jauch-Chara","year":"2012","unstructured":"Jauch-Chara K et al. Intranasal insulin suppresses food intake via enhancement of brain energy levels in humans. Diabetes. 2012;61(9):2261\u20138.","journal-title":"Diabetes"},{"issue":"6","key":"409_CR104","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00125-012-2528-y","volume":"55","author":"M Heni","year":"2012","unstructured":"Heni M et al. Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions. Diabetologia. 2012;55(6):1773\u201382.","journal-title":"Diabetologia"},{"issue":"5","key":"409_CR105","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1185\/030079903125001992","volume":"19","author":"GT McInnes","year":"2003","unstructured":"McInnes GT. The expanding role of angiotensin receptor blockers in the management of the elderly hypertensive. Curr Med Res Opin. 2003;19(5):452\u20135.","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"409_CR106","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1210\/jc.2007-2606","volume":"93","author":"C Benedict","year":"2008","unstructured":"Benedict C et al. Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J Clin Endocrinol Metab. 2008;93(4):1339\u201344.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"409_CR107","doi-asserted-by":"crossref","first-page":"e94845","DOI":"10.1371\/journal.pone.0094845","volume":"9","author":"X Dong","year":"2014","unstructured":"Dong X et al. The relationship between serum insulin-like growth factor I levels and ischemic stroke risk. PLoS One. 2014;9(4):e94845.","journal-title":"PLoS One"},{"issue":"21","key":"409_CR108","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1212\/WNL.0b013e3182752eef","volume":"79","author":"EE Benarroch","year":"2012","unstructured":"Benarroch EE. Insulin-like growth factors in the brain and their potential clinical implications. Neurology. 2012;79(21):2148\u201353.","journal-title":"Neurology"},{"issue":"4","key":"409_CR109","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000054694","volume":"74","author":"W Kern","year":"2001","unstructured":"Kern W et al. Improving influence of insulin on cognitive functions in humans. Neuroendocrinology. 2001;74(4):270\u201380.","journal-title":"Neuroendocrinology"},{"issue":"3","key":"409_CR110","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2337\/diabetes.48.3.557","volume":"48","author":"W Kern","year":"1999","unstructured":"Kern W et al. Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes. 1999;48(3):557\u201363.","journal-title":"Diabetes"},{"issue":"12","key":"409_CR111","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jcem.85.12.7033","volume":"85","author":"S Kalmijn","year":"2000","unstructured":"Kalmijn S et al. A prospective study on circulating insulin-like growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderly. J Clin Endocrinol Metab. 2000;85(12):4551\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"409_CR112","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrn3209","volume":"13","author":"AM Fernandez","year":"2012","unstructured":"Fernandez AM, Torres-Aleman I. The many faces of insulin-like peptide signalling in the brain. Nat Rev Neurosci. 2012;13(4):225\u201339.","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"409_CR113","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0168-8227(87)80039-6","volume":"3","author":"AG Frauman","year":"1987","unstructured":"Frauman AG, Jerums G, Louis WJ. Effects of intranasal insulin in non-obese type II diabetics. Diabetes Res Clin Pract. 1987;3(4):197\u2013202.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1\u20133","key":"409_CR114","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.regpep.2007.06.012","volume":"149","author":"M Hallschmid","year":"2008","unstructured":"Hallschmid M et al. Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders. Regul Pept. 2008;149(1\u20133):79\u201383.","journal-title":"Regul Pept"},{"issue":"5","key":"409_CR115","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/hbm.22304","volume":"35","author":"TM Schilling","year":"2014","unstructured":"Schilling TM et al. Intranasal insulin increases regional cerebral blood flow in the insular cortex in men independently of cortisol manipulation. Hum Brain Mapp. 2014;35(5):1944\u201356.","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"409_CR116","first-page":"372","volume":"27","author":"D Lalej-Bennis","year":"2001","unstructured":"Lalej-Bennis D et al. Six month administration of gelified intranasal insulin in 16 type 1 diabetic patients under multiple injections: efficacy vs subcutaneous injections and local tolerance. Diabetes Metab. 2001;27(3):372\u20137.","journal-title":"Diabetes Metab"},{"issue":"5","key":"409_CR117","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2337\/diacare.10.5.573","volume":"10","author":"AG Frauman","year":"1987","unstructured":"Frauman AG et al. Long-term use of intranasal insulin in insulin-dependent diabetic patients. Diabetes Care. 1987;10(5):573\u20138.","journal-title":"Diabetes Care"},{"issue":"8","key":"409_CR118","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1046\/j.1464-5491.2001.00528.x","volume":"18","author":"D Lalej-Bennis","year":"2001","unstructured":"Lalej-Bennis D et al. Efficacy and tolerance of intranasal insulin administered during 4 months in severely hyperglycaemic Type 2 diabetic patients with oral drug failure: a cross-over study. Diabet Med. 2001;18(8):614\u20138.","journal-title":"Diabet Med"},{"issue":"1","key":"409_CR119","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12031-008-9041-2","volume":"35","author":"D Chesik","year":"2008","unstructured":"Chesik D, De Keyser J, Wilczak N. Insulin-like growth factor system regulates oligodendroglial cell behavior: therapeutic potential in CNS. J Mol Neurosci. 2008;35(1):81\u201390.","journal-title":"J Mol Neurosci"},{"issue":"2\u20133","key":"409_CR120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000065698","volume":"24","author":"A Espinosa-Jeffrey","year":"2002","unstructured":"Espinosa-Jeffrey A et al. Transferrin regulates transcription of the MBP gene and its action synergizes with IGF-1 to enhance myelinogenesis in the md rat. Dev Neurosci. 2002;24(2\u20133):227\u201341.","journal-title":"Dev Neurosci"},{"issue":"14","key":"409_CR121","doi-asserted-by":"crossref","first-page":"9828","DOI":"10.1074\/jbc.274.14.9828","volume":"274","author":"S Heck","year":"1999","unstructured":"Heck S et al. Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB. J Biol Chem. 1999;274(14):9828\u201335.","journal-title":"J Biol Chem"},{"issue":"5","key":"409_CR122","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1046\/j.1471-4159.1999.02037.x","volume":"73","author":"H Matsuzaki","year":"1999","unstructured":"Matsuzaki H et al. Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons. J Neurochem. 1999;73(5):2037\u201346.","journal-title":"J Neurochem"},{"issue":"2","key":"409_CR123","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.nbd.2004.03.001","volume":"16","author":"AM Vincent","year":"2004","unstructured":"Vincent AM et al. IGF-I prevents glutamate-induced motor neuron programmed cell death. Neurobiol Dis. 2004;16(2):407\u201316.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"409_CR124","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1172\/JCI118416","volume":"97","author":"BM Johnston","year":"1996","unstructured":"Johnston BM et al. Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs. J Clin Invest. 1996;97(2):300\u20138.","journal-title":"J Clin Invest"},{"issue":"7","key":"409_CR125","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1210\/er.2004-0024","volume":"26","author":"VC Russo","year":"2005","unstructured":"Russo VC et al. The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev. 2005;26(7):916\u201343.","journal-title":"Endocr Rev"},{"issue":"2\u20133","key":"409_CR126","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-2007-978707","volume":"31","author":"I Torres-Aleman","year":"1999","unstructured":"Torres-Aleman I. Insulin-like growth factors as mediators of functional plasticity in the adult brain. Horm Metab Res. 1999;31(2\u20133):114\u20139.","journal-title":"Horm Metab Res"},{"key":"409_CR127","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/0-387-26274-1_10","volume":"567","author":"I Torres Aleman","year":"2005","unstructured":"Torres Aleman I. Role of insulin-like growth factors in neuronal plasticity and neuroprotection. Adv Exp Med Biol. 2005;567:243\u201358.","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"409_CR128","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1210\/jc.2004-2088","volume":"90","author":"SP Johnsen","year":"2005","unstructured":"Johnsen SP et al. Insulin-like growth factor (IGF) I, \u2212II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab. 2005;90(11):5937\u201341.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"409_CR129","doi-asserted-by":"crossref","first-page":"E1055","DOI":"10.1210\/jc.2010-2802","volume":"96","author":"D Aberg","year":"2011","unstructured":"Aberg D et al. Serum IGF-I levels correlate to improvement of functional outcome after ischemic stroke. J Clin Endocrinol Metab. 2011;96(7):E1055\u201364.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"409_CR130","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.amjmed.2004.02.049","volume":"117","author":"L Denti","year":"2004","unstructured":"Denti L et al. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am J Med. 2004;117(5):312\u20137.","journal-title":"Am J Med"},{"issue":"5","key":"409_CR131","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/01.STR.32.5.1226","volume":"32","author":"WR Schabitz","year":"2001","unstructured":"Schabitz WR et al. Delayed neuroprotective effect of insulin-like growth factor-i after experimental transient focal cerebral ischemia monitored with MRI. Stroke. 2001;32(5):1226\u201333.","journal-title":"Stroke"},{"issue":"1","key":"409_CR132","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12020-007-0012-0","volume":"31","author":"NN Rizk","year":"2007","unstructured":"Rizk NN et al. Insulin like growth factor-1 (IGF-1) decreases ischemia-reperfusion induced apoptosis and necrosis in diabetic rats. Endocrine. 2007;31(1):66\u201371.","journal-title":"Endocrine"},{"issue":"9","key":"409_CR133","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/sj.gt.3302224","volume":"11","author":"M Shirakura","year":"2004","unstructured":"Shirakura M et al. Postischemic administration of Sendai virus vector carrying neurotrophic factor genes prevents delayed neuronal death in gerbils. Gene Ther. 2004;11(9):784\u201390.","journal-title":"Gene Ther"},{"issue":"2","key":"409_CR134","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0006-8993(00)02008-4","volume":"859","author":"JM Wang","year":"2000","unstructured":"Wang JM et al. Reduction of ischemic brain injury by topical application of insulin-like growth factor-I after transient middle cerebral artery occlusion in rats. Brain Res. 2000;859(2):381\u20135.","journal-title":"Brain Res"},{"issue":"1","key":"409_CR135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jstrokecerebrovasdis.2004.01.005","volume":"13","author":"XF Liu","year":"2004","unstructured":"Liu XF et al. The window of opportunity for treatment of focal cerebral ischemic damage with noninvasive intranasal insulin-like growth factor-I in rats. J Stroke Cerebrovasc Dis. 2004;13(1):16\u201323.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"409_CR136","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(01)01982-6","volume":"308","author":"XF Liu","year":"2001","unstructured":"Liu XF et al. Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion. Neurosci Lett. 2001;308(2):91\u20134.","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"409_CR137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2005.05.036","volume":"1053","author":"NN Rizk","year":"2005","unstructured":"Rizk NN, Rafols J, Dunbar JC. Cerebral ischemia induced apoptosis and necrosis in normal and diabetic rats. Brain Res. 2005;1053(1\u20132):1\u20139.","journal-title":"Brain Res"},{"issue":"1","key":"409_CR138","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brainres.2006.04.060","volume":"1096","author":"NN Rizk","year":"2006","unstructured":"Rizk NN, Rafols JA, Dunbar JC. Cerebral ischemia-induced apoptosis and necrosis in normal and diabetic rats: effects of insulin and C-peptide. Brain Res. 2006;1096(1):204\u201312.","journal-title":"Brain Res"},{"issue":"4","key":"409_CR139","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1161\/STROKEAHA.108.528356","volume":"40","author":"R Kooijman","year":"2009","unstructured":"Kooijman R et al. Insulin-like growth factor I: a potential neuroprotective compound for the treatment of acute ischemic stroke? Stroke. 2009;40(4):e83\u20138.","journal-title":"Stroke"},{"key":"409_CR140","doi-asserted-by":"crossref","unstructured":"Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke. 1999;30(12):2752\u20138.","DOI":"10.1161\/01.STR.30.12.2752"},{"issue":"3","key":"409_CR141","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/jpet.108.149807","volume":"330","author":"LR Hanson","year":"2009","unstructured":"Hanson LR et al. Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke. J Pharmacol Exp Ther. 2009;330(3):679\u201386.","journal-title":"J Pharmacol Exp Ther"},{"issue":"24","key":"409_CR142","doi-asserted-by":"crossref","first-page":"8894","DOI":"10.1523\/JNEUROSCI.0698-11.2011","volume":"31","author":"N Akpan","year":"2011","unstructured":"Akpan N et al. Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon\/neuron loss and improves neurological function after stroke. J Neurosci. 2011;31(24):8894\u2013904.","journal-title":"J Neurosci"},{"issue":"1","key":"409_CR143","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3171\/2009.2.JNS081199","volume":"111","author":"L Fletcher","year":"2009","unstructured":"Fletcher L et al. Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation. J Neurosurg. 2009;111(1):164\u201370.","journal-title":"J Neurosurg"},{"issue":"3","key":"409_CR144","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neulet.2009.06.060","volume":"461","author":"JP Yang","year":"2009","unstructured":"Yang JP et al. The dose-effectiveness of intranasal VEGF in treatment of experimental stroke. Neurosci Lett. 2009;461(3):212\u20136.","journal-title":"Neurosci Lett"},{"issue":"7","key":"409_CR145","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/cercor\/bhp216","volume":"20","author":"V Lazzaro Di","year":"2010","unstructured":"Di Lazzaro V et al. Motor cortex plasticity predicts recovery in acute stroke. Cereb Cortex. 2010;20(7):1523\u20138.","journal-title":"Cereb Cortex"},{"issue":"10","key":"409_CR146","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1007\/s00415-012-6480-z","volume":"259","author":"J Witsch","year":"2012","unstructured":"Witsch J et al. Hypoglycemic encephalopathy: a case series and literature review on outcome determination. J Neurol. 2012;259(10):2172\u201381.","journal-title":"J Neurol"},{"issue":"3","key":"409_CR147","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/01.STR.28.3.584","volume":"28","author":"M Fujioka","year":"1997","unstructured":"Fujioka M et al. Specific changes in human brain after hypoglycemic injury. Stroke. 1997;28(3):584\u20137.","journal-title":"Stroke"},{"issue":"9","key":"409_CR148","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/STROKEAHA.111.618850","volume":"42","author":"GW Albers","year":"2011","unstructured":"Albers GW et al. Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke. 2011;42(9):2645\u201350.","journal-title":"Stroke"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-015-0409-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12975-015-0409-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-015-0409-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T10:15:02Z","timestamp":1717928102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12975-015-0409-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,5]]},"references-count":148,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["409"],"URL":"https:\/\/doi.org\/10.1007\/s12975-015-0409-7","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,5]]}}}